Cargando…
The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging
BACKGROUND: Tumor suppressor gene p16 promoter hypermethylation has been widely studied in colorectal cancer (CRC), yet its clinicopathological significance remains controversial. The methylation alterations of other regions within p16 gene are still rarely researched. The present study aimed to exp...
Autores principales: | Ye, Xiaoxia, Mo, Mingming, Xu, Simin, Yang, Qingjin, Wu, Minhua, Zhang, Junjie, Chen, Bin, Li, Jian, Zhong, Yu, Huang, Qionglin, Cai, Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198490/ https://www.ncbi.nlm.nih.gov/pubmed/30348132 http://dx.doi.org/10.1186/s12885-018-4921-5 |
Ejemplares similares
-
Site-Specific Hypermethylation of SST 1stExon as a Biomarker for Predicting the Risk of Gastrointestinal Tract Cancers
por: Dai, Xiantong, et al.
Publicado: (2022) -
Prognostic Value of KRAS Exon 3 and Exon 4 Mutations in Colorectal Cancer Patients
por: Guo, Tianan, et al.
Publicado: (2021) -
SCTR hypermethylation is a diagnostic biomarker in colorectal cancer
por: Li, DaPeng, et al.
Publicado: (2020) -
Novel Nine-Exon AR Transcripts (Exon 1/Exon 1b/Exons 2–8) in Normal and Cancerous Breast and Prostate Cells
por: Hu, Dong Gui, et al.
Publicado: (2016) -
Natural Exon Skipping Sets the Stage for Exon Skipping as Therapy for Dystrophic Epidermolysis Bullosa
por: Bremer, Jeroen, et al.
Publicado: (2019)